Clinical Study

Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience

Table 3

Dosimetric estimates for kidney and bone marrow.

MeanMedianSDRange

90Y-kidney dose (Gy/GBq) 2 . 4 𝐸 + 0 0 1 . 5 𝐸 + 0 0 1.90.32–8.90
90Y-bone marrow dose (Gy/GBq) 9 . 7 𝐸 0 2 5 . 8 𝐸 0 2 0.10.0047–0.51
177Lu-kidney dose (Gy/GBq) 3.9 𝐸 0 1 2 . 5 𝐸 0 1 0.30.05–1.47
177Lu-bone marrow dose (Gy/GBq) 2 . 8 1 𝐸 0 2 1 . 2 9 𝐸 0 2 0.040.0163–0.256